Frankfurt - Delayed Quote EUR

Autolus Therapeutics plc (6A3A.F)

1.4600
+0.0900
+(6.57%)
As of 8:19:53 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
9,011
10,120
1,698
6,194
1,507
Cost of Revenue
29,338
11,387
0
--
--
Gross Profit
-20,327
-1,267
1,698
--
--
Operating Expense
246,942
239,522
177,226
149,087
141,881
Operating Income
-267,269
-240,789
-175,528
-142,893
-140,374
Net Non Operating Interest Income Expense
31,391
23,061
-31,562
-7,197
-843
Other Income Expense
1,506
-1,406
-1,312
1,523
-821
Pretax Income
-234,372
-219,134
-208,402
-148,567
-142,038
Tax Provision
3,761
1,528
-19
272
58
Net Income Common Stockholders
-238,133
-220,662
-208,383
-148,839
-142,096
Diluted NI Available to Com Stockholders
-238,133
-220,662
-208,383
-148,839
-142,096
Basic EPS
-0.88
-0.86
-1.20
-1.57
-1.97
Diluted EPS
-0.88
-0.86
-1.20
-1.57
-1.97
Basic Average Shares
266,149.9980
255,161.0380
173,941.9260
94,993.4000
72,084.0780
Diluted Average Shares
266,149.9980
255,161.0380
173,941.9260
94,993.4000
72,084.0780
Total Operating Income as Reported
--
-241,426
-179,701
--
--
Total Expenses
276,280
250,909
177,226
149,087
141,881
Net Income from Continuing & Discontinued Operation
-238,133
-220,662
-208,383
-148,839
-142,096
Normalized Income
-238,810.0300
-219,377.4600
-206,849.1399
-148,432.1500
-141,602.5200
Interest Income
31,559
32,355
13,505
1,708
262
Interest Expense
168
9,294
45,067
8,905
1,105
Net Interest Income
31,391
23,061
-31,562
-7,197
-843
EBIT
-234,204
-209,840
-163,335
-139,662
-140,933
EBITDA
-226,017
-202,124
-156,770
-132,240
-132,475
Reconciled Cost of Revenue
29,338
11,387
0
--
--
Reconciled Depreciation
8,187
7,716
6,565
7,422
8,458
Net Income from Continuing Operation Net Minority Interest
-238,133
-220,662
-208,383
-148,839
-142,096
Total Unusual Items Excluding Goodwill
857
-1,626
-1,534
-515
-676
Total Unusual Items
857
-1,626
-1,534
-515
-676
Normalized EBITDA
-226,874
-200,498
-155,236
-131,725
-131,799
Tax Rate for Calcs
0.0002
0.0002
0
0.0002
0.0003
Tax Effect of Unusual Items
179.9700
-341.4600
-0.1399
-108.1500
-182.5200
12/31/2021 - 7/30/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

473A.BE Adaptimmune Therapeutics PLC
0.2440
-2.40%
 
9LB.BE Legend Biotech Corp
25.60
+2.40%
 
9LB.DU Legend Biotech Corp
25.20
+0.80%
 
22UA.F BioNTech SE
87.85
+2.09%
 
ADAP Adaptimmune Therapeutics plc
0.2711
-3.28%
 
LEGN Legend Biotech Corporation
28.29
-1.63%
 
ALLO Allogene Therapeutics, Inc.
1.1400
+5.56%
 
CRBU Caribou Biosciences, Inc.
1.1200
+2.75%
 
BNTX BioNTech SE
97.53
-1.04%